Ligand to acquire XOMA Royalty for $739 million in cash deal Apr 27, 2026 07:01AM
Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator Apr 27, 2026 07:00AM